Differential risk of remission and ESRD in childhood FSGS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differential risk of remission and ESRD in childhood FSGS

Published:2006-01-05 Issue:3 Volume:21 Page:344-349
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Gipson Debbie S.,Chin Hyunsook,Presler Trevor P.,Jennette Caroline,Ferris Maria E.,Massengill Susan,Gibson Keisha,Thomas David B.

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-005-2097-0.pdf

Reference30 articles.

1. Mitsnefes M, Stablein D (2005) Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis 45:309–315

2. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362:629–639

3. (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561–564

4. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC (2005) Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 16:1061–1068

5. Cattran D (2005) Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 15:1188–1194

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study;Pediatric Nephrology;2024-06-04

2. A new index for the outcome of focal segmental glomerulosclerosis;Scientific Reports;2024-04-09

3. Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset refractory steroid-resistant nephrotic syndrome: a multicenter study;2024-02-23

4. Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis;Human Molecular Genetics;2024-01-15

5. Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial);Clinical and Experimental Nephrology;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3